Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, July 17, 2013

Ebselen stroke

You will need your doctor to followup on this, the link doesn't point to these statements. This sounds extremely important,  that if your doctor/hospital doesn't know about this, its time to fire them.

Glutathione peroxidase-1 as a novel therapeutic target for COPD

R Vlahos, S Bozinovski - Redox Report, 2013
... They demonstrated that early treatment (ie patients who started ebselen within 24 h of stroke
onset) with ebselen (150 mg bid) improved the outcome of acute ischaemic stroke. ... Ebselen in
acute ischemic stroke: a placebo-controlled, double-blind clinical trial.
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)